This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Alk-Abello A/s. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Eckhard-Carl Albrecht Puchert: Innovator in Mucosal Allergen-Specific Immunotherapy
Introduction
Eckhard-Carl Albrecht Puchert is a notable inventor based in Hamburg, Germany. He has made significant contributions to the field of immunotherapy, particularly in the area of allergen-specific treatments. His innovative approach aims to improve the quality of life for individuals suffering from seasonal allergies.
Latest Patents
Puchert holds a patent for "Mucosomal allergen-specific immunotherapy with initial dosing after start of pollen season." This invention relates to a method of administering allergen-specific immunotherapy that is initiated after the onset of the pollen season. The therapy utilizes a solid dosage form of the seasonal allergen, which is administered daily. Notably, the same dose can be maintained throughout the treatment period, eliminating the need for up-dosing.
Career Highlights
Eckhard-Carl Albrecht Puchert is associated with Alk-Abello A/S, a company known for its advancements in allergy immunotherapy. His work at the company has focused on developing innovative solutions to address the challenges faced by allergy sufferers.
Conclusion
Eckhard-Carl Albrecht Puchert's contributions to mucosal allergen-specific immunotherapy represent a significant advancement in the field of allergy treatment. His innovative patent reflects a commitment to improving patient outcomes and enhancing the effectiveness of immunotherapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile